# LightPathTM Imaging System for Ex-vivo Assessment of Margin and Lymph Node Status in Breast Cancer Surgical Specimens

> **NCT02037269** · — · COMPLETED · sponsor: **Lightpoint Medical Limited** · enrollment: 25 (actual)

## Conditions studied

- Breast Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT02037269
- **Lead sponsor:** Lightpoint Medical Limited
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2016-06
- **Final completion:** 2016-07
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2016-08-10

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02037269

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02037269, "LightPathTM Imaging System for Ex-vivo Assessment of Margin and Lymph Node Status in Breast Cancer Surgical Specimens". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02037269. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*